Hanseatic Management Services’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Hanseatic Management Services's KRYS Position: Q3 2026 in Review
Hanseatic Management Services increased its Krystal Biotech (KRYS) stake by 2% in Q3 2026, buying an estimated $21.8K and bringing the position to 3,183 shares worth $1.06M. The position accounts for 0.87% of the portfolio, ranked #45.
Hanseatic Management Services first reported a position in KRYS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.16M in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Hanseatic Management Services held 3,183 shares of Krystal Biotech worth $1.06M as of Q3 2026.
- Hanseatic Management Services bought 63 Krystal Biotech shares in Q3 2026, an estimated $21.8K.
- Krystal Biotech made up 0.87% of Hanseatic Management Services's portfolio in Q3 2026, its #45 holding.
- Hanseatic Management Services first reported a position in Krystal Biotech in Q1 2026 and has held it in 3 quarters since.
- Hanseatic Management Services's Krystal Biotech position peaked at $1.16M in Q2 2026.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Hanseatic Management Services's 13F filing for Q3 2026, filed 22 Oct 2026.